6533b829fe1ef96bd128a5e4

RESEARCH PRODUCT

Use of Helmet CPAP in COVID-19 – A practical review

M.f. CeredaAndrea CortegianiHouman AmirfarzanKay B. LeissnerCesare GregorettiRoman SchumannT.g. Gaulton

subject

Pulmonary and Respiratory Medicinemedicine.medical_specialtyARDSCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentEconomic shortageReviewRespiratory failureAir contamination03 medical and health sciencesDiseases of the respiratory system0302 clinical medicineMedicineIntubationHumans030212 general & internal medicineIntensive care medicineMechanical ventilationHelmetNoninvasive VentilationRC705-779Continuous Positive Airway Pressurebusiness.industrySARS-CoV-2Oxygen Inhalation TherapyCOVID-19medicine.diseaseLow noise030228 respiratory systemRespiratory failureHead Protective DevicesARDSNon-invasive mechanical ventilationbusinessRespiratory InsufficiencyVentilator Weaning

description

Helmet CPAP (H-CPAP) has been recommended in many guidelines as a noninvasive respiratory support during COVID-19 pandemic in many countries around the world. It has the least amount of particle dispersion and air contamination among all noninvasive devices and may mitigate the ICU bed shortage during a COVID surge as well as a decreased need for intubation/mechanical ventilation. It can be attached to many oxygen delivery sources. The MaxVenturi setup is preferred as it allows for natural humidification, low noise burden, and easy transition to HFNC during breaks and it is the recommended transport set-up. The patients can safely be proned with the helmet. It can also be used to wean the patients from invasive mechanical ventilation. Our article reviews in depth the pathophysiology of COVID-19 ARDS, provides rationale of using H-CPAP, suggests a respiratory failure algorithm, guides through its setup and discusses the issues and concerns around using it.

yearjournalcountryeditionlanguage
2021-02-01Pulmonology
10.1016/j.pulmoe.2021.01.008http://europepmc.org/articles/PMC7849604